Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
2015/10/29 by Carol E. DeSantis, Carol DeSantis, Stacey A. Fedewa +4 · 31 citations
Medicine · #Global Cancer Incidence and Screening #Colorectal Cancer Screening and Detection #Cancer Risks and Factors
paper · pdf · doi:10.3322/caac.21320
Abstract
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 231,840 new cases of invasive breast cancer and 40,290 breast cancer deaths are expected to occur among US women in 2015. Breast cancer incidence rates increased among non-Hispanic black (black) and Asian/Pacific Islander women and were stable among non-Hispanic white (white), Hispanic, and American Indian/Alaska Native women from 2008 to 2012. Although white women have historically had higher incidence rates than black women, in 2012, the rates converged. Notably, during 2008 through 2012, incidence rates were significantly higher in black women compared with white women in 7 states, primarily located in the South. From 1989 to 2012, breast cancer death rates decreased by 36%, which translates to 249,000 breast cancer deaths averted in the United States over this period. This decrease in death rates was evident in all racial/ethnic groups except American Indians/Alaska Natives. However, the mortality disparity between black and white women nationwide has continued to widen; and, by 2012, death rates were 42% higher in black women than in white women. During 2003 through 2012, breast cancer death rates declined for white women in all 50 states; but, for black women, declines occurred in 27 of 30 states that had sufficient data to analyze trends. In 3 states (Mississippi, Oklahoma, and Wisconsin), breast cancer death rates in black women were stable during 2003 through 2012. Widening racial disparities in breast cancer mortality are likely to continue, at least in the short term, in view of the increasing trends in breast cancer incidence rates in black women.
Citations
Cited by
- What can be done to encourage women from Black, Asian and minority ethnic backgrounds to attend breast screening? A qualitative synthesis of barriers and facilitators
- Angiopoietin pathway gene expression associated with poor breast cancer survival
- Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
- Fuzzy Semantic Segmentation of Breast Ultrasound Image with Breast Anatomy Constraints
- T-SYNTH: A Knowledge-Based Dataset of Synthetic Breast Images
- Expression of circulating miR‐17, miR‐25, and miR‐133 in breast cancer patients
- Understanding and effectively addressing breast cancer in African American women: Unpacking the social context. [europepmc]
- Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival. [europepmc]
- Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. [europepmc]
- Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. [europepmc]
- SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis. [europepmc]
- State of the evidence 2017: an update on the connection between breast cancer and the environment. [europepmc]
- Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013. [europepmc]
- Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. [europepmc]
- Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures. [europepmc]
- SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2. [europepmc]
- Trends in breast cancer mortality by stage at diagnosis among young women in the United States. [europepmc]
- Endocrine Therapy Nonadherence and Discontinuation in Black and White Women. [europepmc]
- The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. [europepmc]
- Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1. [europepmc]
- Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women. [europepmc]
- Health and Racial Disparity in Breast Cancer. [europepmc]
- The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced Apoptosis of Breast Cancer 4T1 Cells. [europepmc]
- Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies. [europepmc]
- Cancer health disparities in racial/ethnic minorities in the United States. [europepmc]
- Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. [europepmc]
- Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial. [europepmc]
- Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer. [europepmc]
- Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. [europepmc]
- Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. [europepmc]
- Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence. [europepmc]
Related